Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth Consecutive Year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth Consecutive Year


Humana Specialty Pharmacy has won the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth year in a row. The award recognizes best-in-class customer satisfaction

Dexcom Announces Upcoming Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor

AMN Healthcare Announces First Quarter 2022 Results: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Announces First Quarter 2022 Results


AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2022 financial

Acadia Healthcare to Present at May Conferences: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare to Present at May Conferences


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at two healthcare conferences in May.



On Wednesday, May 11, 2022, the Company will present at the BofA

U.S. FDA Renews Annual DILIsym Software Licenses for 2022: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
U.S. FDA Renews Annual DILIsym Software Licenses for 2022


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. Food and Drug

Premier Inc. to Participate in BofA Securities 2022 Healthcare Conference on May 10, 2022: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in BofA Securities 2022 Healthcare Conference on May 10, 2022


Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the

Quidel Reports First Quarter 2022 Financial Results
Quidel Reports First Quarter 2022 Financial Results


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the

Acadia Healthcare Reports First Quarter 2022 Results: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Reports First Quarter 2022 Results


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2022.



First Quarter Highlights




  • Revenue totaled $616.7 million, an

Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference:
Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2022 Health Care Conference on Tuesday, May 10, 2022, at 9:20 AM (PDT) at the

Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 third quarter ended March 31, 2022.



"As we

Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time


DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The

Dexcom Reports First Quarter 2022 Financial Results: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Reports First Quarter 2022 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2022.



First Quarter 2022 Financial Highlights:




  • Revenue grew 25% versus the same

DGAP-News: MicroVision to Participate in Upcoming Investor Conferences
DGAP-News: MicroVision to Participate in Upcoming Investor Conferences
DGAP-News: MicroVision to Participate in Upcoming Investor Conferences
Simulations Plus Successfully Delivers FDA-Funded Project: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Successfully Delivers FDA-Funded Project


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the completion of a newly funded

DGAP-News: MicroVision Announces First Quarter 2022 Results
DGAP-News: MicroVision Announces First Quarter 2022 Results
DGAP-News: MicroVision Announces First Quarter 2022 Results
DexCom präsentiert auf der internationalen ATTD-Konferenz sein erweitertes CGM-Portfolio, das Menschen mit Diabetes mehr Wahlmöglichkeiten bietet: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
DexCom präsentiert auf der internationalen ATTD-Konferenz sein erweitertes CGM-Portfolio, das Menschen mit Diabetes mehr Wahlmöglichkeiten bietet


DexCom, Inc. (Nasdaq: DXCM), der Weltmarktführer im Bereich des kontinuierlichen Glukosemonitoring für Diabetespatienten, wird auf der 15. International Conference on Advanced Technologies and

DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
Chemed Reports First-Quarter 2022 Results:
Chemed Reports First-Quarter 2022 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24:
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24


Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24. The company

DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase for the first time its new global portfolio of real-time continuous

Premier, Inc. Declares Quarterly Cash Dividend: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share of Class

Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new

DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
STAAR Surgical to Report First Quarter Results on May 4, 2022: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report First Quarter Results on May 4, 2022


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release